Platinum Investment Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-218,336
| Closed | -$904K | – | 138 |
|
|
2022
Q2 | $904K | Hold |
218,336
| – | – | 0.03% | 102 |
|
|
2022
Q1 | $1.27M | Hold |
218,336
| – | – | 0.04% | 98 |
|
|
2021
Q4 | $1.64M | Hold |
218,336
| – | – | 0.05% | 99 |
|
|
2021
Q3 | $1.97M | Hold |
218,336
| – | – | 0.06% | 100 |
|
|
2021
Q2 | $2.61M | Hold |
218,336
| – | – | 0.06% | 86 |
|
|
2021
Q1 | $2.74M | Hold |
218,336
| – | – | 0.06% | 76 |
|
|
2020
Q4 | $3.41M | Hold |
218,336
| – | – | 0.08% | 66 |
|
|
2020
Q3 | $2.06M | Sell |
218,336
-22,176
| -9% | -$210K | 0.05% | 80 |
|
|
2020
Q2 | $2.16M | Sell |
240,512
-5,328
| -2% | -$47.7K | 0.05% | 81 |
|
|
2020
Q1 | $1.57M | Buy |
245,840
+49,575
| +25% | +$316K | 0.04% | 79 |
|
|
2019
Q4 | $1.64M | Buy |
196,265
+27,680
| +16% | +$232K | 0.03% | 71 |
|
|
2019
Q3 | $1.53M | Hold |
168,585
| – | – | 0.03% | 72 |
|
|
2019
Q2 | $1.82M | Hold |
168,585
| – | – | 0.04% | 67 |
|
|
2019
Q1 | $1.61M | Buy |
168,585
+29,893
| +22% | +$285K | 0.04% | 75 |
|
|
2018
Q4 | $1.59M | Buy |
138,692
+85,792
| +162% | +$985K | 0.05% | 57 |
|
|
2018
Q3 | $897K | Hold |
52,900
| – | – | 0.03% | 77 |
|
|
2018
Q2 | $751K | Buy |
+52,900
| New | +$751K | 0.02% | 77 |
|